Hansheng Zhou Net Worth

Hansheng Zhou biography

Dr. Hansheng Zhou Ph.D. is an Independent Director of the Company. Dr. Zhou is a well-respected and seasoned executive with over 28 years of experience in the science and technology industries in China. He currently serves as Chief Executive Officer and Chairman of Wuhan Dangdai Science & Technology Industries Group Co., Ltd. (“Wuhan Dangdai”), a China based privately held conglomerate with a substantial medical and pharmaceutical portfolio in China. Dr. Zhou previously served as Chief Financial Officer and Managing Director of Wuhan Humanwell Healthcare Group Co., Ltd. He holds a bachelor’s degree in Cell Biology and masters in Animal Biology from Wuhan University and has also earned his PhD degree in Applied Chemistry from Beijing Institute of Technology. Dr. Zhou is a member of the Company’s Compensation Committee. In considering Dr. Zhou’s eligibility to serve on the Board, the Board considered Mr. Zhou’s leadership experience in managing both large pharmaceutical company in China and multinationals in substantially similar industries.

What is the salary of Hansheng Zhou?

As the Independent Director of Cellular Biomedicine Inc, the total compensation of Hansheng Zhou at Cellular Biomedicine Inc is $121,128. There are 5 executives at Cellular Biomedicine Inc getting paid more, with Andrew Chan having the highest compensation of $847,684.

How old is Hansheng Zhou?

Hansheng Zhou is 56, he's been the Independent Director of Cellular Biomedicine Inc since 2016. There are 4 older and 5 younger executives at Cellular Biomedicine Inc. The oldest executive at Cellular Biomedicine Group Inc is Edward Schafer, 74, who is the Non-Executive Independent Director.

What's Hansheng Zhou's mailing address?

Hansheng's mailing address filed with the SEC is 19925 Stevens Creek Blvd #100, Cupertino, CA 95014, USA.

Insiders trading at Cellular Biomedicine Inc

Over the last 13 years, insiders at Cellular Biomedicine Inc have traded over $5,441,696 worth of Cellular Biomedicine Inc stock and bought 262,367 units worth $1,621,804 . The most active insiders traders include Keith Wong, Wei (William) Cao, and Pak To Venture Garden Ltd F.... On average, Cellular Biomedicine Inc executives and independent directors trade stock every 84 days with the average trade being worth of $911,976. The most recent stock trade was executed by Wen Tao Liu on 10 April 2018, trading 22,444 units of CBMG stock currently worth $348,555.

What does Cellular Biomedicine Inc do?

Cellular Biomedicine Inc executives and stock owners

Cellular Biomedicine Inc executives and other stock owners filed with the SEC include:

• Andrew Chan,
  Senior Vice President - Corporate Business Development, General Counsel, Chief Legal Officer, Secretary
• Bizuo Liu,
  Chief Executive Officer, Chief Financial Officer, Director
• Yihong Yao,
  Chief Scientific Officer
• Wen Liu,
  Independent Director
• Terry Belmont,
  Independent Chairman of the Board
• Hansheng Zhou,
  Independent Director
• Chun Kwok Alan Au,
  Independent Director
• Edward Schafer,
  Non-Executive Independent Director
• Gang Ji,
  Independent Director
• Sarah Kelly,
  Director of Corporate Communications
• Darren O'Brien,
  Independent Director
• Health Investment Holdings ...,
  
• Wei (William) Cao,
  Chief Executive Officer
• Bosun Hau,
  
• Tony Liu,
  CEO, CFO
• Nadir Patel,
  
• Pak To Venture Garden Ltd F...,
  
• David Bolocan,
  Director
• Keith Wong,
  Director
• Jianping Dai,
  Director